Fresenius Medical Care AG & Co. (FMS)
(Delayed Data from NYSE)
$21.07 USD
+0.34 (1.64%)
Updated May 30, 2024 04:00 PM ET
After-Market: $21.08 +0.01 (0.05%) 7:24 PM ET
3-Hold of 5 3
A Value C Growth B Momentum A VGM
Brokerage Reports
0 items in cart
Fresenius Medical Care AG & Co. KGaA [FMS]
Reports for Purchase
Showing records 121 - 140 ( 142 total )
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Weak 1Q13 results; we see no reason to step in, maintain HOLD
Provider: FELTL & COMPANY
Analyst: WEIGHT M
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
3Q12 results disappoint on the top and bottom line; maintaining HOLD
Provider: FELTL & COMPANY
Analyst: WEIGHT M
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
FMS 4Q highlights solid operating results; 2012 guidance inline
Provider: FELTL & COMPANY
Analyst: WEIGHT M
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Survey sees further opportunity to reduce patient costs; near-term margin expansion?
Provider: FELTL & COMPANY
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Facility survey: Changes are underway and more diverse than expected
Provider: FELTL & COMPANY
Analyst: HOERNEMANN J
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Eastern European acquisition looks expensive, but will likely be accretive
Provider: FELTL & COMPANY
Analyst: HOERNEMANN J
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Transition relief? It?s possible, but we remain skeptical
Provider: FELTL & COMPANY
Analyst: HOERNEMANN J
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Services drive third quarter, choice to opt in expected given cost saving opportunity
Provider: FELTL & COMPANY
Analyst: HOERNEMANN J
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Managed care survey indicates shift in dialysis provider contracts
Provider: FELTL & COMPANY
Analyst: HOERNEMANN J
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Survey says: Providers evaluating ways to lower costs under bundling
Provider: FELTL & COMPANY
Analyst: HOERNEMANN J
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
OIG Report Highlights Value of Annual Update, Purchasing Power of Large Chains
Provider: FELTL & COMPANY